Efficacy of Adding Oral Amisulpride to Dual Prophylaxis for Postoperative Nausea and Vomiting in Patients at High Risk for Nausea and Vomiting Undergoing Gynecological Surgery

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Efficacy of Adding Oral Amisulpride to Dual Prophylaxis for Postoperative Nausea and Vomiting in Patients at High Risk for Nausea and Vomiting Undergoing Gynecological Surgery — Stella

Home/Post Operative Nausea and Vomiting (PONV)/

View on ClinicalTrials.gov

Recruiting

Back to Post Operative Nausea and Vomiting (PONV) trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

Brazil

Hospital da Mulher, São Paulo, São Paulo

Key details

Phase

Safety & dosing

Sponsor

Instituto do Cancer do Estado de São Paulo

Collaborators

University Medical Center Groningen

Enrollment target

~276 participants

Started

April 2025

Primary completion

March 2027

Age range

18 Years and older

Sex

Female only

Last updated April 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.